Group 1 - Dongyangguang plans to jointly increase capital in a subsidiary for the acquisition of 100% equity in Qinhuai Data China, with a total investment of 75 billion yuan [2] - Baiyin Nonferrous Metals is under investigation by the China Securities Regulatory Commission for suspected information disclosure violations [3] - Beida Pharmaceutical intends to issue H-shares and apply for listing on the Hong Kong Stock Exchange [5] Group 2 - ST Tianmao plans to withdraw its A-share listing and transfer to the National SME Share Transfer System after delisting [5] - Goldwind Technology has approved an investment agreement for a 3GW wind-hydrogen-ammonia integration project in Inner Mongolia, with a total investment of approximately 189.2 billion yuan [6] - Langzi Co. has signed an agreement to acquire 67.5% of Chongqing Milan Baiyu Shiguang Medical Beauty Hospital for 92.475 million yuan [7] Group 3 - Dongfang Guoxin is establishing a joint venture with Beijing Shunyi Financial Holdings to focus on computing power infrastructure and services, with a registered capital of 300 million yuan [8] - ST Hezhong's chairman is under bail pending trial, but the company's operations remain unaffected [9] - Kangzhi Pharmaceutical's major shareholder is transferring 22.758 million shares at a price of 5.34 yuan per share, totaling 122 million yuan [9] Group 4 - Shenzhen Airport reported a passenger throughput of 5.807 million in August, a year-on-year increase of 4.07% [10] - Lin Yang Energy won a bid for a project with a total amount of approximately 244.08 million yuan [11] - Fullpower New Materials received a government subsidy of 20 million yuan, which is expected to positively impact its 2025 profits [14] Group 5 - BYD executives and core personnel collectively increased their holdings by 48.82 million shares, totaling 52.3278 million yuan [16] - Hualing Steel's major shareholder increased its stake by 6.90862 million shares, representing a 1% increase in ownership [16]

Mergers and Acquisitions - Dongyangguang plans to jointly increase capital in Yichang Dongshu No.1 Investment Co., Ltd. with an associated party, with capital increases of 3.5 billion and 4 billion yuan respectively. The company intends to acquire 100% equity of Qinhuai Data's China operations through its wholly-owned subsidiary [1] - Aimeike has completed the acquisition of controlling interest in South Korea's REGEN Biotech, Inc., obtaining 59.5% equity after the completion of the transaction [2] - Longzi Co., Ltd. plans to acquire 67.5% equity of Chongqing Time through a cash payment of 92.475 million yuan [3] Shareholding Changes - Hongbai New Materials' controlling shareholder plans to reduce its stake by up to 3%, which includes a maximum of 6.5 million shares through centralized bidding and 13 million shares through block trading [4] - BYD executives and core personnel collectively increased their holdings by 488,200 shares, with a total investment of 52.3278 million yuan [5] - Sichuan Road and Bridge's controlling shareholder intends to reduce its stake by up to 2%, equating to a maximum of 17.4 million shares [6] Regulatory Issues - Baiyin Nonferrous Metals has received a notice from the China Securities Regulatory Commission regarding an investigation for suspected violations of information disclosure [7] - Huangting International's wholly-owned subsidiary's asset, the Crystal Island International Shopping Center, was put up for auction but ultimately failed to sell [8]

Group 1 - Zhejiang Rongzao has a small sales volume in the robot components sector [1] - Jin Feng Technology plans to invest 18.92 billion yuan in a wind power hydrogen ammonia project [1] - Lin Yang Energy won a bid for approximately 244 million yuan from the Southern Power Grid [1] Group 2 - Yingli Co., Ltd. intends to acquire 77.9385% of Youte Li [2] - Jiajiayue has repurchased 1.57% of its shares [2] - Xiantan Co., Ltd. achieved chicken product sales revenue of 516 million yuan in August [2] Group 3 - Longhua Chemical and its concerted parties plan to reduce their holdings by no more than 3% [2] - Hualing Steel plans to increase its holdings by 1%-2% [2] - Menguanli intends to raise no more than 980 million yuan for a project to produce 30,000 tons of lithium-ion battery cathode materials annually [3]

Group 1 - The company announced the acquisition of a 67.5% stake in Chongqing Milan Baiyu Time Plastic Surgery Hospital for a cash consideration of 92.475 million yuan [1] - The company plans to relinquish its preferential purchase rights for a 35% stake in Nanjing Huamei Beauty Hospital [1] - Chongqing Time is a specialized medical beauty service provider with a total operating area of 5,600 square meters [1]

每经记者｜王琳 每经编辑｜魏官红 并购重组 东阳光：拟与关联方收购秦淮数据中国100%股权 东阳光公告，公司与关联方深圳市东阳光实业发展有限公司拟共同增资宜昌东数一号投资有限责任公 司，增资金额分别为35亿元、40亿元。同时，东数一号拟通过全资孙公司宜昌东数三号投资有限责任公 司收购秦淮数据中国区业务经营主体100%股权。 爱美客：收购韩国REGEN控股权交割完成 爱美客公告，公司方面已完成收购韩国REGEN Biotech,Inc.公司（以下简称韩国REGEN）控股权的交 割。爱美客国际已取得韩国相关部门颁发的大法院登记证明和外国投资者登记证明。公司持有爱美客国 际70％股权，本次交割完成后，爱美客国际持有韩国REGEN 85％股权，公司进而实际取得韩国REGEN 59.5％股权。 朗姿股份：拟收购重庆时光67.5%股权 朗姿股份公告，公司全资子公司北京朗姿医疗管理有限公司拟以9247.50万元现金收购重庆米兰柏羽时 光整形美容医院有限公司67.50%的控股权。 增减持 宏柏新材：控股股东拟减持不超3%公司股份 宏柏新材公告，控股股东宏柏化学有限公司拟通过集中竞价交易的方式减持不超过650万股公司股份， 占 ...

Group 1 - Tianpu Co., Ltd. experienced a significant stock price increase of 185.29% from August 22 to September 10, leading to a halt for further investigation due to abnormal trading [4] - Baiyin Nonferrous Metals has been investigated by the China Securities Regulatory Commission for suspected violations of information disclosure [5] - Qingshan Paper Industry confirmed that its production and operational activities are normal, with no significant changes in daily operations [6] Group 2 - Aoyang Health announced that its stock will continue to be suspended due to ongoing negotiations regarding a share transfer by its controlling shareholder [7] - ST Jinke will implement a capital reserve transfer to increase share capital, resulting in a one-day stock suspension [8] - ST Haofeng's stock will resume trading on September 11 after a share transfer agreement was signed, making Zhixin Network the controlling shareholder [9] Group 3 - Fushun Special Steel's stock will be suspended for one day due to a tender offer for shares by Ningbo Meishan Free Trade Port Zone Jincheng Shazhou Equity Investment Co., Ltd. [10] - Fuliwang's subsidiary plans to invest 500 million yuan in a high-end wire material research and production project [11] - ST Tianmao's application for voluntary delisting has been accepted by the Shenzhen Stock Exchange [12] Group 4 - Dongyangguang plans to jointly increase capital in a subsidiary for the acquisition of Qinhuai Data China [13] - Betta Pharmaceuticals intends to issue H-shares and apply for listing on the Hong Kong Stock Exchange [14] - Longzi Co., Ltd. plans to acquire a 67.5% stake in Chongqing Time for approximately 92.475 million yuan [15] Group 5 - Dongfang Guoxin plans to establish a joint venture for a technology company with Shunyi Jin Kong [16] - ST Lianshi signed a pre-restructuring investment agreement with selected investors [18] - Shaanxi Construction Group won four construction projects worth over 5 billion yuan in August [19] Group 6 - Dema Technology won a smart logistics project with a well-known Latin American e-commerce giant, valued at approximately 290 million yuan [20] - Mongolian Grass Ecology's subsidiary led a consortium to win a 225 million yuan ecological restoration project [21] - Dajin Heavy Industry signed a long-term production agreement for offshore wind power foundations, with a total value of about 1.25 billion yuan [24] Group 7 - Zhendong Medical's controlling shareholder plans to transfer 5% of the company's shares [25] - ST Hezhong's controlling shareholder is under bail pending trial, but company operations remain unaffected [26] - BYD's senior management and core personnel collectively increased their holdings by approximately 52.33 million yuan [27] Group 8 - Jiahe Meikang's shareholder plans to reduce its stake by up to 1.94% [28] - Sichuan Road and Bridge's controlling shareholder plans to reduce its stake by up to 2% [30] - Lanke Technology's shareholders plan to reduce their holdings by up to 2% [31]

在内生+外延的双重驱动下，朗姿股份(002612)进一步加快了泛时尚产业布局速度，并推动朗姿医疗美 容业务的全国布局。 9月10日晚间，朗姿股份发布公告，拟斥资近亿元收购重庆米兰柏羽时光整形美容医院有限公司（下 称"重庆米兰柏羽"）控股权，上市公司医美业务盈利能力有望得到进一步优化与改善，且医美业务资产 规模、收入规模和利润规模将持续增加。 标的未来三年净利不低于3101万元 9月10日，朗姿股份下属全资子公司北京朗姿医疗管理有限公司（以下简称"北京朗姿医管"）与芜湖博 恒二号创业投资合伙企业（有限合伙）（下称"博恒二号"）签署了《股权转让协议》，北京朗姿医管拟 以现金方式收购博恒二号持有的重庆米兰柏羽67.50%的控股权。 根据资产评估报告显示，截至2025年3月31日，在采用收益法评估后，重庆米兰柏羽100%股权评估值结 果为1.37亿元。基于以上评估结果，经交易双方协商一致，重庆米兰柏羽67.50%股权的转让价格为 9247.50万元。此次股权转让完成后，北京朗姿医管将持有重庆米兰柏羽67.5%控股权，后者将纳入上市 公司合并报表范围。 据悉，重庆米兰柏羽是一家专业从事医疗美容服务，总营业面积达5600 ...

Group 1 - The core point of the article is that Langzi Co., Ltd. is acquiring a 67.50% stake in Chongqing Milan Baiyu Time Aesthetic Medical Hospital for a cash consideration of 92.475 million yuan, which is part of the company's strategy to enhance its presence in the aesthetic medical industry [1][2] - The acquisition is aimed at accelerating the company's dual-driven strategy of both organic growth and external expansion in the fashion industry, thereby increasing the scale and competitiveness of its aesthetic medical business [2] - Following the completion of the transaction, Chongqing Time will become a subsidiary of the company, which is expected to improve the profitability of its aesthetic medical business and increase the asset, revenue, and profit scale of this segment [2] Group 2 - Chongqing Time is a specialized aesthetic medical service provider with a total operating area of 5,600 square meters, located in a prime area of Chongqing, which is popular among young people [1] - The hospital is equipped with advanced facilities, including two thousand-level laminar flow operating rooms, two ten-thousand-level laminar flow operating rooms, and various treatment rooms for skin and dental care [1] - The company aims to provide high-quality, comprehensive, and refined aesthetic medical services in accordance with international standards [1]

Group 1 - The core viewpoint of the article is that Langzi Co., Ltd. is accelerating its expansion in the aesthetic medical industry through the acquisition of a controlling stake in Chongqing Milan Baiyu Time Aesthetic Medical Hospital, enhancing its competitiveness and scale in the market [1][2] - The acquisition involves Langzi's wholly-owned subsidiary, Beijing Langzi Medical Management, purchasing 67.50% of Chongqing Time for a total price of 92.475 million yuan [1] - Chongqing Time is a specialized medical aesthetic service provider with a total operating area of 5,600 square meters, located in a prime area of Chongqing, featuring advanced facilities and a variety of medical aesthetic services [1] Group 2 - This acquisition is part of Langzi's strategy to drive growth through both internal and external means, aiming to become a leader in the aesthetic medical industry [2] - Following the completion of the transaction, Chongqing Time will become a subsidiary of Langzi, which is expected to optimize and improve the profitability of its aesthetic medical business [2] - The transaction will lead to an increase in the asset scale, revenue scale, and profit scale of Langzi's aesthetic medical business, as it will be included in the company's consolidated financial statements [2]

Core Viewpoint - Langzi Co., Ltd. announced the acquisition of a 67.5% stake in Chongqing Milan Baiyu Time Aesthetic Medical Hospital Co., Ltd. for a cash consideration of 92.475 million yuan, which will be consolidated into the company's financial statements after the transaction is completed [1]. Group 1 - Langzi Co., Ltd.'s wholly-owned subsidiary, Beijing Langzi Medical Management, signed a share transfer agreement with Boheng No. 2 [1]. - The acquisition price for the 67.5% stake in Chongqing Time is set at 92.475 million yuan [1]. - Following the completion of the share transfer, Chongqing Time will be included in Langzi Co., Ltd.'s consolidated financial statements [1].